PharmaShots | Incisive News in 3 Shots

Subscribe Now

European Union

Astellas' Xtandi (enzalutamide) Receives EU's Approval for Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)

Astellas' Xtandi (enzalutamide) Receives EU's Approval for Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer...

October 30, 2018

Pfizer Receives EU Approval for Xeljanz (tofacitinib citrate- JAK3i) for Moderate to Severe UC Patients

Pfizer Receives EU Approval for Xeljanz (tofacitinib citrate- JAK3i) for Moderate to Severe UC Patients

August 1, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us